NNutrition Read More Dietary supplement makers push the FDA to allow peptides and other new ingredients30 March 2026 Makers of dietary supplements are pushing the Food and Drug Administration to expand the types of ingredients they…
MMedication Read More FDA approves new ‘Wegovy HD’ with triple the dosage of the semaglutide medication24 March 2026 The US Food and Drug Administration announced on Thursday its approval of a new, higher-dose Wegovy (semaglutide) injection.…
MMedication Read More Pa. lawmaker proposes bill targeting compounded GLP-1 medications24 March 2026 ‘A true public health crisis’: Pa. lawmaker proposes bill targeting compounded GLP-1 medications TOLD THEM ABOUT WHY HE…
MMedication Read More Nearly 90,000 bottles of children’s liquid pain medication recalled23 March 2026 WASHINGTON (AP) — Nearly 90,000 bottles of a children’s pain reliever have been recalled due to reports of…
MMedication Read More Coming Soon: ‘Wegovy HD’22 March 2026 Federal regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy that may…
NNutrition Read More Defining ‘ultraprocessed’ could spur research, school lunch rules – Roll Call20 March 2026 The Trump administration is nearing a key milestone in its “Make America Healthy Again” agenda: proposing a definition of…
MMedication Read More Ozempic is getting generics as low as $15 — what it means for Americans19 March 2026 The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the…
NNutrition Read More Multivitamin Recall Update for 25 States As FDA Sets Risk Level14 March 2026 A chewable multivitamin distributed across 25 states has been recalled after federal inspectors found the product contained lower‑than‑intended…
MMedication Read More FDA sends letter to Novo Nordisk over potential GLP-1 side effects13 March 2026 The U.S. Food and Drug Administration sent a warning letter this month to Novo Nordisk, the maker of…
MMedication Read More FDA sends letter to Novo Nordisk over potential GLP-1 side effects13 March 2026 The U.S. Food and Drug Administration sent a warning letter this month to Novo Nordisk, the maker of…